Keyword: Cosentyx

Tremfya

9. Tremfya

Johnson & Johnson's Tremfya was the first selective IL-23 inhibitor to land on the scene.
Skyrizi

6. Skyrizi

Despite multiple drugs working through inhibiting inflammatory interleukins, AbbVie's Skyrizi is still carving out a meaningful share.